Arcadia Biosciences, Inc. (NASDAQ:RKDA) Short Interest Up 2,437.2% in August

Arcadia Biosciences, Inc. (NASDAQ:RKDAGet Free Report) was the target of a significant increase in short interest in the month of August. As of August 14th, there was short interest totaling 88,674 shares, an increase of 2,437.2% from the July 30th total of 3,495 shares. Based on an average daily trading volume, of 307,856 shares, the short-interest ratio is currently 0.3 days. Approximately 3.9% of the company’s shares are short sold.

Arcadia Biosciences Trading Up 5.0%

NASDAQ RKDA opened at $0.51 on Thursday. Arcadia Biosciences has a 12 month low of $0.38 and a 12 month high of $6.71. The stock has a market cap of $1.24 million, a P/E ratio of -0.11 and a beta of 0.56. The stock’s fifty day moving average price is $0.64 and its 200-day moving average price is $1.11.

Arcadia Biosciences (NASDAQ:RKDAGet Free Report) last posted its quarterly earnings results on Thursday, August 13th. The basic materials company reported ($2.09) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.56) by ($1.53). Arcadia Biosciences had a negative return on equity of 183.50% and a negative net margin of 234.53%.The company had revenue of $1.44 million during the quarter, compared to analysts’ expectations of $1.90 million.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings cut Arcadia Biosciences from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday, June 25th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, Arcadia Biosciences has an average rating of “Sell”.

View Our Latest Stock Report on RKDA

About Arcadia Biosciences

(Get Free Report)

Arcadia Biosciences, Inc, founded in 2002 and headquartered in Davis, California, is an agricultural biotechnology company dedicated to developing crops and food ingredients that promote health and sustainability. By harnessing advanced genomics and precision‐breeding technologies, Arcadia creates proprietary trait platforms designed to enhance crop performance, nutritional value, and resilience to environmental stressors. The company’s scientific expertise focuses on non-transgenic approaches, enabling the delivery of novel traits without introducing foreign DNA.

Arcadia’s operations span two main segments: Crop Traits and Food Ingredients.

Recommended Stories

Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.